Human cytomegalovirus non-primary infection during pregnancy: antibody response, risk factors and newborn outcome. (October 2022)

• Record Type: Journal Article
• Authors: Zelini, Paola; d'Angelo, Piera; De Cicco, Marica; Achille, Cristian; Sarasini, Antonella; Fiorina, Loretta; Cirasola, Daniela; Marazzi, Valentina; Piccini, Stefania; Furione, Milena; Arossa, Alessia; Muscettola, Giulia; Spinillo, Arsenio; Lilleri, Daniele
• Is Part Of: Clinical microbiology and infection. Volume 28:Number 10(2022)
• Page Start: 1375
• Page End: 1381
• Publication Date: 2022-10
• Subjects: Antibody -- Congenital infection -- Human cytomegalovirus -- Non-primary infection -- Pregnancy; Medical microbiology -- Periodicals; Diagnostic microbiology -- Periodicals; Communicable diseases -- Periodicals; Infection -- Periodicals; 616.01
• DOI: 10.1016/j.cmi.2021.09.013
• Languages: English
• ISSNs: 1198-743X

Abstract

Abstract: Objectives: Human cytomegalovirus (HCMV) non-primary infections can occur in pregnant women and may result in congenital infection. Comprehensive studies investigating the frequency, characteristics, risk factors and immune response of non-primary infection in pregnancy are missing, while the rate of vertical transmission is not known. Methods: HCMV non-primary infection was investigated prospectively in 250 pregnant women. Blood and urine samples as well as saliva and vaginal swabs were collected at 13, 21 and 31 weeks of gestation and at delivery. HCMV-DNA and specific IgG and IgM levels were determined. Results: Overall, 105/250 pregnant women (42.0%) developed non-primary infection. HCMV-DNA was detected more frequently in vaginal secretions (84/250 of the women, 33.6%) than in urine (35/250, 14.0%), saliva (26/250, 10.4%) and blood (7/250, 3.0%). The rate of HCMV non-primary infection increased significantly with the progression of pregnancy (from 12.9% in the first trimesters of gestation to 21.9% at delivery, p < 0.01). IgM was detected in 25/250 of the women (10.0%), with no association with non-primary infection, while anti-gB IgG was significantly higher (p < 0.01) in women with non-primary infection. Age and close contact with children were not associated with non-primary infection. No woman with non-primary infection transmitted the infection to the fetus (95% confidence interval of transmission rate: 0–3.5%). Discussion: Although HCMV non-primary infection is frequent during pregnancy, the rate of congenital infection as a consequence of non-primary infection is likely to be ≤ 3.5%.